TerminatedPhase 4ketamine
Effect of Ketamine on Postoperative Clinical Outcomes
Sponsored by Cedars-Sinai Medical Center
NCT ID
NCT01365195
Target Enrollment
21 participants
Start Date
2011-05
Est. Completion
2014-12
About This Study
The purpose of this research is to evaluate the effectiveness of ketamine as an analgesic adjuvant in decreasing the narcotic (opioids) analgesics during surgery, on pain management and on the later recovery after surgery in patients undergoing colorectal surgery.
Conditions Studied
Interventions
- •Placebo
- •Ketamine high-dose
- •Ketamine low-dose
Eligibility
Age:18 Years - 80 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria 1. Patients scheduled to undergo small and/or large partial bowel resection via laparotomy or laparoscopy 2. Willingness and ability to sign an informed consent document 3. No allergies to anesthetic or analgesic medications 4. 18 - 80 years of age 5. American Society of Anesthesiologists (ASA) Class I - III adults of either sex Exclusion Criteria 1. Inability to comprehend the pain assessment tools 2. Patients with known allergy, hypersensitivity or contraindications to anesthetic or analgesic medications 3. Patients with clinically-significant heart disease including arrhythmias and significant hypertension, brain aneurysms, prior history of cerebral vascular accident (CVA), or chronic renal insufficiency 4. Prior abdominal surgery 5. History of abdominal carcinomatosis 6. History of radiation enteritis; 7. Patients with history of hepatic, renal, cardiac failure, organ transplant, or diabetes 8. Patients with seizures 9. Morbid obesity (body mass index \>40) 10. Pregnant or lactating women 11. Subjects with a history of alcohol or drug abuse within the past 3 months 12. Any other conditions or use of any medication which may interfere with the conduct of the study 13. Prophylactic Nasogastric Tube (NGT) use 14. Individuals with significant manic disorders including: schizophrenia, or bipolar disorder or psychosis 15. Individuals with asthma and/or thyroid diseases
Study Locations (1)
Cedars Sinai Medical center
Los Angeles, California, United States